Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Roche and Gilead Sciences to copromote hepatitis treatment in the U.S.

Oct. 4, 1996

Joint venture formed for development of oral heparin

Oct. 4, 1996

Schering-Plough seeks approval for corticosteroid nasal spray in rhinitis

Oct. 4, 1996

Atypical antipsychotic receives approvals

Oct. 4, 1996

First approval for a DTaP-IPV vaccine

Oct. 4, 1996

First combined hepatitis A/B vaccine approved

Sep. 27, 1996

New hay fever remedy available for the fall allergy season

Sep. 27, 1996

Orphan drug finally approved for urea cycle disorders

Sep. 27, 1996

First localized treatment for fatal brain cancer approved by the FDA

Sep. 27, 1996

Anika receives European marketing approval for osteoarthritis product

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.